Published in Hopkins HIV Rep on July 01, 2003
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA (2002) 10.40
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis (2005) 8.77
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med (2008) 3.67
The future of antibiotics and resistance. N Engl J Med (2013) 3.47
Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med (2004) 3.30
Improvement in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis (2012) 2.70
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep (2002) 2.70
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clin Infect Dis (2011) 2.49
Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol (2008) 2.40
It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis (2005) 2.40
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med (2002) 2.36
Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary? Clin Infect Dis (2005) 2.06
Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol (2011) 1.94
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis (2009) 1.83
HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections. J Acquir Immune Defic Syndr (2008) 1.57
The new Clostridium difficile--what does it mean? N Engl J Med (2005) 1.53
Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Ann Intern Med (2005) 1.52
Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol (2005) 1.41
Antiretroviral therapy where resources are limited. N Engl J Med (2003) 1.27
Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med (2005) 1.23
The role of anaerobic bacteria in lung abscess. Clin Infect Dis (2005) 1.20
Pilot study of a web-based antibiotic decision management guide. J Am Coll Surg (2006) 1.13
Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients. PLoS One (2011) 1.12
Decline in microbial studies for patients with pulmonary infections. Clin Infect Dis (2004) 1.11
Anti-infective research and development--problems, challenges, and solutions. Lancet Infect Dis (2007) 1.05
Antibacterial resistance leadership group: open for business. Clin Infect Dis (2014) 1.04
Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis (2012) 1.03
Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. AIDS Patient Care STDS (2003) 1.01
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis (2012) 0.93
Clostridium difficile: an under-recognized cause of reactive arthritis? Clin Rheumatol (2007) 0.92
New drugs for Clostridium difficile infection. Clin Infect Dis (2006) 0.91
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. J Infect Dis (2002) 0.89
Pneumonia treatment process and quality. Arch Intern Med (2002) 0.87
Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS (2013) 0.87
Association between oral fluoroquinolones and retinal detachment. Am J Ophthalmol (2012) 0.81
New guidelines for management of dyslipidemia from IDSA and the ACTG. Hopkins HIV Rep (2004) 0.79
Management of hepatitis C: a review of the NIH Consensus Development Conference. Hopkins HIV Rep (2002) 0.78
The DHHS adult ART guidelines are revised. Hopkins HIV Rep (2005) 0.78
Challenges in the management of serious infections. Clin Infect Dis (2006) 0.78
International HIV Workshop on Management of Treatment-Experienced Patients. Hopkins HIV Rep (2002) 0.77
Antibiotic administration in community-acquired pneumonia. Chest (2004) 0.77
Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients. JAMA (2002) 0.77
Smallpox vaccination and the patient with an organ transplant. Clin Infect Dis (2003) 0.76
Screening for HIV. Ann Intern Med (2005) 0.75
Use of the computer program GIDEON at an inpatient infectious diseases consultation service. Clin Infect Dis (2006) 0.75
FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection. Hopkins HIV Rep (2005) 0.75
USPHS updates occupational HIV post-exposure prophylaxis guidelines. Hopkins HIV Rep (2006) 0.75
DHHS issues adult guideline revisions. HIV Clin Trials (2004) 0.75
Testing for competence in HIV care. IAPAC Mon (2003) 0.75
DHHS issues adult guideline revisions. Hopkins HIV Rep (2004) 0.75
Update on opportunistic infections. Hopkins HIV Rep (2002) 0.75
Smallpox vaccination and HIV infection. Hopkins HIV Rep (2003) 0.75
3rd IAS conference: prevention highlights. Hopkins HIV Rep (2005) 0.75
Panel on clinical practices issues revised adult ART guidelines. Hopkins HIV Rep (2003) 0.75
Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections. HIV Clin Trials (2002) 0.75
Treatment of opportunistic infections. Hopkins HIV Rep (2004) 0.75
Report from ICAAC: update on opportunistic infections. Hopkins HIV Rep (2002) 0.75